Bristol Myers Squibb (CELG-RI) FCF Payout Ratio (QoQ) (2009 - 2026)

Bristol Myers Squibb (CELG-RI) FCF Payout Ratio (QoQ) (2009 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Bristol Myers Squibb - - 8.07 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 115.41%
Dec 31, 2025 273.21%
Sep 30, 2025 -40.60%
Jun 30, 2025 -52.21%
Mar 31, 2025 147.60%
Dec 31, 2024 29.91%
Sep 30, 2024 -60.84%
Jun 30, 2024 24.06%
Mar 31, 2024 60.70%
Dec 31, 2023 9.49%
Sep 30, 2023 -63.26%
Jun 30, 2023 65.49%
Mar 31, 2023 14.85%
Dec 31, 2022 15.31%
Sep 30, 2022 5,460.33%
Jun 30, 2022 -98.19%
Mar 31, 2022 13.22%
Dec 31, 2021 34.79%
Sep 30, 2021 7,672.47%
Jun 30, 2021 -99.08%